GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...

European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by an advance in oil and ...

(Reuters) -Bristol Myers Squibb said on Friday its blockbuster drug Reblozyl in combination with another therapy failed to ...

The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

US and European stock markets stalled or trimmed gains on Friday after a bullish week buoyed by US data and upbeat company ...

The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs ...

European and Asian stocks markets closed out the week broadly higher Friday following Wall Street's latest record highs ...

Proposals by Robert F. Kennedy Jr. and Bernie Sanders range from more disclosures in commercials to an outright ban.

U.S. stocks appear poised for a positive opening on Friday, as strong earnings from major companies throughout the week have ...